Get an early start on your networking for South Summit 2018 by checking out our marketplace, where you can find profiles on all the Startups, Corporate Partners, Accelerators and Institutions who will be at the event.
I look for a relationships with a Working on Who can help my project via
Amadix is a leading molecular diagnostics company focused on developing innovative diagnostic tests for early cancer detection in blood. The mission of the company is saving lives, developing disruptive technologies to detect the tumour a few years in advance, to win the battle against cancer and extend people lives. The company’s products are oriented to non-invasive early cancer detection, avoiding the complications of existing invasive procedures, as tumor biopsies. Colofast, the most advanced product, is a blood-based test for colorectal cancer (CRC) diagnosis, based on a unique combination of cutting-edge biomarkers, which have never been used in CRC as of today (micro-RNAs). It is indicated to screen healthy population 50 to 85 years old, for early detection of the tumour an premalignant lessions. Colofast is expected to be commercialized in 2019. The company’s test pipeline includes two innovative blood-based products for early detection of lung and pancreatic cancer.
If you have a proposal on some of these areas, we will gladly analyze: